Gallbladder Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Gallbladder Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-02-07Clinical Trial Update: Study of PEGPH20 With Cisplatin (CIS) and Gemcitabine (GEM); PEGPH20 With Atezolizumab (ATEZO), CIS, and GEM; and CIS and GEM Alone in Participants With Previously Untreated, Unresectable, Locally Advanced, or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder Adenocarcinoma [Phase 1]
Phase 1 trial evaluating PEGPH20 with cisplatin and gemcitabine, with or without atezolizumab, in previously untreated unresectable/metastat…
-
CLINICAL_TRIALS trial_result · 2018-04-25Clinical Trial Update: Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer [Phase 2]
This clinical trial update reports the results of a Phase 2 study evaluating capecitabine, oxaliplatin, and bevacizumab with radiation thera…
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder Cancer [Phase 2]
A Phase 2 trial evaluating the combination of gemcitabine, oxaliplatin, and bevacizumab in biliary tract cancers (including gallbladder aden…